RA Capital Management - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
RA Capital Management ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2018$43,116,000
-33.7%
3,021,466
-3.2%
2.51%
-27.7%
Q3 2018$64,985,000
-12.0%
3,119,7780.0%3.47%
-27.5%
Q2 2018$73,845,000
+257.2%
3,119,778
+111.0%
4.79%
+156.6%
Q3 2017$20,673,000
+466.4%
1,478,742
+47.9%
1.87%
+406.2%
Q2 2014$3,650,0001,000,0000.37%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,850,000$12,513,0004.70%
Avoro Capital Advisors LLC 7,344,177$23,869,0004.19%
NEXTHERA CAPITAL LP 1,263,276$4,106,0002.52%
Opaleye Management Inc. 1,200,000$3,900,0002.04%
First Light Asset Management, LLC 992,867$3,227,0001.39%
DAFNA Capital Management LLC 566,796$1,842,0001.28%
Ghost Tree Capital, LLC 2,000,000$6,500,0001.05%
Iguana Healthcare Management, LLC 600,000$1,950,0000.35%
PURA VIDA INVESTMENTS, LLC 319,565$1,039,0000.32%
J. Goldman & Co LP 1,696,699$5,514,0000.31%
View complete list of IMMUNOMEDICS INC shareholders